ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: Lenhard Elected President Of ACS; House Science Committee Approves CRADA Bill

November 17, 1995

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

May 6, 1983

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

Without Advisor’s Input, Healy Approves Protocol For Gene Therapy

January 15, 1993

NCI Offers 200 Cell Lines to Scientist

May 6, 1983